RISPERDAL BREAST CANCER LAWSUIT
PRACTICE AREAS
Johnson & Johnson Knew.
They Didn't Tell You.
Risperdal has been linked to a significantly elevated breast cancer risk. If you or a family member was prescribed this drug, you may be entitled to compensation — at no cost to pursue.
Jump to a section
No fee unless we win • Confidential • Nationwide representation
Breast Cancer Diagnosis After Taking Antipsychotic Drug Risperdal?
Diagnosed with breast cancer after taking Risperdal or risperidone? Our attorneys can help you file a Risperdal breast cancer lawsuit to seek compensation and justice for the physical and emotional toll your family has suffered. Our Risperdal breast cancer lawyers are actively investigating claims and want to hear your story.
With over 30 years of experience, board certification in personal injury trial law, and more than $5 billion recovered for victims, our Risperdal breast cancer attorney team has the record and resources to hold Johnson & Johnson accountable.
If you or a family member is a long-term Risperdal user, our legal team is actively helping individuals nationwide file malignant breast tumor and breast carcinoma lawsuits. Johnson & Johnson and Janssen Pharmaceuticals aren’t new defendants for our legal team. We have a well-established reputation in dangerous product and antipsychotic litigation against Johnson & Johnson.
- Dennis Reich was appointed as a member of the Plaintiffs’ Steering Committee for the Risperdal Litigation (JCCP 4775) in California (the prior gynecomastia case also in association with prolactin hormones), helping direct the litigation. That Risperdal lawsuit settled for $800 million.
- Our law firm has represented numerous young men in individual Invega and Risperdal injury claims.
- Our law firm secured a $775 million settlement in the Xarelto case and another success in the benzene-sunscreen lawsuit; Johnson & Johnson was a defendant in both.
See if you qualify, then contact our pharmaceutical litigation attorneys for a free consultation: 713-622-7271
What Is the Risperdal Breast Cancer Lawsuit?
Risperdal (risperidone) is an atypical antipsychotic medication manufactured by the pharmaceutical company Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, that healthcare providers have used to treat conditions since the early 1990s.
The original FDA approval was for treating schizophrenia, but it was later approved to treat schizophrenia and bipolar disorder, as well as the irritability effects in autistic children. It’s been widely prescribed off-label for a range of mental health conditions and mood disorders.
Atypical antipsychotic medications cause the human body to overproduce prolactin, a hormone linked to abnormal breast growth and breast tissue development. The connection between high-prolactin drugs and higher doses of moderately prolactin-elevating antipsychotic drugs has been well-established in the scientific community since the 70’s.
The Risperdal lawsuit alleges that Johnson & Johnson has concealed this evidence. Despite the pharmaceutical company’s knowledge dating back to the 90’s, the antipsychotic drug’s label denied any cancer risk until 2025, stating:
“Neither clinical trials nor epidemiological studies conducted to date have shown an association between chronic administration of this class of drugs and tumorigenesis in humans.”
The first Risperdal lawsuit for cancer, Brown v. Johnson & Johnson (Case No. 25CV119808), was filed in Alameda County Superior Court in April 2025 on behalf of plaintiff Bridgett Brown, who received a breast cancer diagnosis after taking the antipsychotic drug and was never adequately warned of the health risk.
This litigation is separate from earlier gynecomastia, or abnormal development of male breast growth.
The Risperdal breast cancer lawsuits represent emerging mass tort litigation.
This law firm is the best if you have a Risperdal, Risperidone or Invega case. They talk to you every step of the way and make sure you're always taken care of. Thank you so much everyone here that has helped me so far.
— Pharmaceutical Injury Client
Does Risperidone Cause Breast Cancer?
Yes, research has linked Risperdal and its generic, risperidone, to an increased risk of breast cancer diagnoses, particularly through elevated prolactin levels. Risperdal blocks dopamine receptors, which causes the pituitary gland to overproduce prolactin, a hormone that can stimulate breast tissue development and, over time, significantly increase breast cancer risk.
Risperdal Linked to Breast Cancer – Studies and Evidence
Here’s the basic link between Risperdal and breast cancer diagnoses:
Risperdal blocks dopamine receptors → this removes the body’s natural brake on prolactin production → this causes hyperprolactinemia → elevated prolactin levels activate the hormones that promote cell growth, and in this case, abnormal breast growth and tumorigenesis, or tumor development.
Here are the most recent studies cited in emerging litigation:
In 2025, researchers reviewed 15 recent studies covering over one million individuals. The researchers found a 59% increased breast cancer risk for women taking the antipsychotic drug, Risperdal. (Bird, 2025)
A 2024 Swedish registry study of 132,061 women taking risperidone/Risperdal found a 47% increased breast cancer risk after five or more years of exposure to prolactin-elevating antipsychotic medications. (Solmi, 2024)
Other health studies have confirmed the link between Risperdal and breast cancer diagnoses:
- Researchers: Harvard Medical School and Brigham and Women’s Hospital
- Published: Cancer Research (2013) and Breast Cancer Research (2023)
Research Findings:
A 20-year study found that women with abnormally high levels of prolactin had the highest potential risk of a breast cancer diagnosis. The breast cancer risk was most profound for Estrogen Receptor-positive (ER+) tumors, where high prolactin levels were associated with a 52% increased risk in postmenopausal women.
In the 2023 update, researchers noted that increased prolactin levels in premenopausal women doubled the breast cancer risk for tumors that express the pSTAT5 transcription factor.
- Researchers: A group pooling investigations across the world’s major biobanks
- Published: Breast Cancer Research (2024/2025)
Research Findings:
This compared women with the highest and lowest levels of prolactin. Researchers confirmed a 30% increased breast cancer risk in women with elevated prolactin.
- Researchers: Karolinska Mammography Project for Risk Prediction of Breast Cancer team in Sweden
- Published: Breast Cancer Research and Treatment (2010/2016 )
Research Findings:
The study investigated how tumors morphed. It found that for premenopausal women with high prolactin levels, there was a 77% increased risk of breast cancer compared to those with normal prolactin.
This study, conducted ~10 years ago, also established a link between elevated prolactin and higher breast density. This is one of the strongest risk factors for developing breast cancer in itself.
Are There Any Links Between Autism and Breast Cancer?
While there’s no biological link, many patients with autism were prescribed Risperdal off-label. This exposed them to a significantly increased breast cancer risk. Risperdal is used to combat the effects of irritability in autistic children. This dramatically increased long-term use of a dangerous antipsychotic drug in a vulnerable population that was never warned about long-term health risks.
If you or your autistic child developed cancer after taking antipsychotic drug, Risperdal or its generic version, you may have a valid claim. Contact a Risperdal breast cancer lawyer for a free case evaluation.
Do You Qualify To File a Risperdal Breast Cancer Lawsuit?
You may be eligible to file a claim if you meet the following criteria:
- You took Risperdal (risperidone), Invega (paliperidone), or Zyprexa (olanzapine)
- You were diagnosed with breast cancer after taking the medication for five years or more
- Your diagnosis falls within your state’s statute of limitations
These are general criteria. Whether you qualify depends on your prescription and medical history. Children, men, and women taking one of these antipsychotic drugs for mental health conditions like schizophrenia, bipolar disorder, autism effects, or prescribed the medication for off-label use, may qualify for significant financial compensation.
The science links Risperdal and breast cancer. Now, our legal team is working to hold the pharmaceutical companies accountable.
Not sure if you qualify? Our Risperdal lawyers offer free and confidential consultations. We'll review medical records, prescription history, and address concerns at no cost.
Free Consultation — 713-622-7271 Prefer to write to us?Can I Sue for Breast Cancer Diagnosis If I Took The Generic Version of Risperidone?
Yes, patients who took generic risperidone may have legal options, though the process is more complex. Under current consumer safety laws, generic drug manufacturers are typically shielded from certain manufacturer-failing-to-warn claims. However, depending on your state, prescription, and medical history, you may be able to join the Risperdal lawsuit or file an individual claim.
The legal theory that our attorneys are using in Risperdal lawsuits is innovator liability. This argues that Eli Lilly, Johnson & Johnson, and its subsidiary Janssen Pharmaceuticals, the antipsychotic drug manufacturer, control the drug label that generic risperidone must mirror. Since Johnson & Johnson and Eli Lilly, the pharmaceutical companies that control the drug labeling, failed to adequately warn patients, they’re responsible for all drug versions.
Why this matters:
Plaintiff Bridgett Brown, the individual who filed the first lawsuit, alleges she was prescribed both Risperdal and Zyprexa, making a mixed-use case central to emerging litigation.
Contact a Risperdal breast cancer lawsuit attorney for a free and confidential consultation to discuss seeking justice and financial compensation. Our legal team will determine whether you can join the Risperdal lawsuit, whether you took the brand-name or generic.
Can Men File a Lawsuit If They Developed Breast Cancer After Taking Risperdal?
Yes, men can file a Risperdal breast cancer lawsuit. This is a risk linked to the antipsychotic drug’s prolactin-elevating effects. Male patients have recovered compensation, and claims for tumors associated with abnormal male breast growth are taken just as seriously as those of women diagnosed with cancer.
A Risperdal breast cancer lawyer from our law firm can help you seek justice and compensation against negligent drug makers.
What is the Deadline to File a Risperdal Lawsuit For Breast Cancer Diagnosis?
The statute of limitations varies by state court, but is typically 2-3 years from the diagnosis or when patients discovered the connection between Risperdal and breast cancer.
Contact a Risperdal breast cancer lawyer for a free consultation to protect your legal rights.
Potential Compensation For Patients Who Developed Breast Cancer After Taking Risperdal
A successful Risperdal breast cancer lawsuit may qualify patients for compensation across several categories:
| Type of Damage | What It Covers |
|---|---|
| Medical Bills and Future Medical Care Expenses | All costs for cancer treatment: surgery, chemotherapy, radiation, reconstructive procedures, ongoing and future medical care expenses |
| Lost Wages | Income lost during cancer treatment, recovery, and any period of disability |
| Diminished Earning Capacity | Long-term or permanent reduction in wages |
| Pain and Suffering | Physical pain endured as a result of your diagnosis and cancer treatment |
| Emotional Distress | Anxiety, depression, trauma, and the psychological impact of developing breast cancer |
| Loss of Quality of Life | Loss of enjoyment, independence, and life experiences caused by the physical and emotional toll of your cancer diagnosis |
Lawsuit History & What It Means For You
J&J Has Been Here Before.
We Beat Them Before. We're Ready to Fight Again.
Gynecomastia surgery runs $5,000–$15,000. The bulk of each $95–97K recovery went far beyond medical bills — covering emotional distress and J&J's deliberate failure to warn.
When a company accidentally misses a risk, payouts are low. Our firm proved J&J and Janssen Pharmaceuticals actively misled consumers — and the settlements reflected it.
They put profits over your safety. We made them pay for it before. Breast cancer damages are significantly larger — and we're ready.
Antipsychotics and Breast Cancer Risk
Risperdal (risperidone) is unique in that it is both an atypical antipsychotic drug and a prolactin-elevating antipsychotic medication.
Dopamine naturally regulates the hormone responsible for breast growth and milk production. Because antipsychotic drugs block dopamine receptors, they can lead to increased prolactin levels.
Atypical antipsychotic drugs were designed to avoid the potential side effects of older, dangerous drugs. However, a few atypical medications still act as prolactin-elevating drugs.
- Risperdal (risperidone) and Invega (paliperidone): are atypical drugs but bind so tightly to dopamine receptors that they often cause severe hyperprolactinemia, sometime even more than older prolactin elevating drugs.
- Prolactin-Sparing Atypical Medications: Antipsychotic drugs like Seroquel (quetiapine), Clozaril (clozapine), and Abilify (aripiprazole) clear out of dopamine receptors quickly and don’t result in elevated prolactin levels with prolonged use.
Antipsychotic Drugs With the Highest Risk of Breast Cancer Development: Highest Prolactin-Elevating Potential
The following antipsychotic medications have the highest prolactin-elevating potential, resulting in prolonged spikes.
Women taking high-prolactin drugs in this category have a 62% higher breast cancer risk compared to those taking non-elevating antipsychotic drugs, according to epidemiological studies conducted by researchers at Washington University School of Medicine in St. Louis.
- Risperdal
- Invega
- Haldol
- Amisulpride
Antipsychotic Drugs With a Moderately Increased Risk of Breast Cancer Development: Moderately Increased Prolactin Levels
While these antipsychotic drugs don’t significantly increase prolactin levels as aggressively as the first category, they’re still prolactin-elevating enough that they’re considered dangerous drugs.
Women taking these antipsychotic medications face a 54% increased breast cancer risk, according to the same researchers at WashU Medicine.
- Zyprexa
- Latuda
- Fanapt
Other Antipsychotic Medications Named in Dangerous Drug Litigation
Risperdal isn’t the only antipsychotic medication with allegations that pharmaceutical companies failed to adequately warn patients with schizophrenia and bipolar disorder. Two other widely prescribed medications are named in claims for the same prolactin-elevating mechanism from patients who weren’t adequately warned, coming forward.
Zyprexa Breast Cancer Lawsuit (Olanzapine)
In April 2025, attorneys filed a lawsuit in California alleging that Eli Lilly knowingly concealed evidence that Zyprexa causes breast cancer, the first claim to make the allegation. Several studies have found that there’s a 54% increased risk for women taking Zyprexa, or its generic.
In 2026, Zyprexa breast cancer lawsuits are moving forward in Alameda County Superior Court.
Contact a Zyprexa lawsuit attorney from our law firm to explore your legal options for recovery.
Invega Breast Cancer Lawsuit (Paliperidone)
In October 2025, the patients’ lawsuit alleged that Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, failed to adequately warn patients and healthcare providers about the potential connection between the antipsychotic drug and cancer risk, pointing to evidence of drug-induced hyperprolactinemia as a contributing factor for both women and men.
In 2026, our antipsychotic medication lawyers are representing individuals across the country in Invega lawsuits alleging that the antipsychotic drugs caused breast cancer diagnoses.
Risperdal Breast Cancer Lawsuit Update 2026
Pharmaceutical litigation is gaining momentum in 2026. If you or a loved one developed breast cancer after taking Risperdal or its generic version, you need to act fast.
Many cases are being filed by individuals nationwide in mass-tort litigation, not as a Risperdal class action. No multidistrict dangerous drug litigation has been established for Risperdal breast cancer claims yet. This means each plaintiff’s claim is evaluated individually.
This is a significant advantage for victims harmed by antipsychotic drugs: your medical history, pain and suffering, medical bills, ongoing care, lost wages, and other losses drive your recovery, not a settlement averaged with thousands of other patients.
The key milestones in the Risperdal breast cancer litigation include:
Plaintiff Bridget Brown’s case marked the beginning of the dangerous drug litigation against pharmaceutical companies Johnson & Johnson and Eli Lilly. The complaint established the framework that our Risperdal lawyers are using to pursue numerous lawsuits on behalf of victims across the country.
The judge granted the plaintiff’s motion to remand cases from federal jurisdiction back to Alameda County Superior Court, a major victory for emerging lawsuits. State courts, like Alameda County, generally favor plaintiffs over dangerous product and drug manufacturers over federal courts. This keeps Risperdal lawsuits on favorable grounds.
There have been no major updates as of mid June 2026. We are continuing to monitor progress.
For men and women diagnosed with cancer, most state courts allow 2-3 years from the date you were diagnosed with breast cancer or when you discovered the connection between the antipsychotic drug and cancer.
Prescription records, doctor notes, medical records, and memories of the initial physical and emotional toll are far easier to retain early in the process.
The Risperdal lawsuit docket is expected to grow throughout 2026. Contacting a Risperdal breast cancer lawsuit attorney means your claim is filed before state courts are congested.
When You're Taking On Johnson & Johnson,
The Attorneys You Choose Matter.
Here's what sets our Risperdal breast cancer legal team apart from every other firm.
30+ Years of Pharmaceutical & Personal Injury Litigation
Decades of experience holding drug manufacturers accountable for the harm caused by dangerous medications.
AV Preeminent Rated by Martindale-Hubbell
The highest peer-review rating available to attorneys — a distinction granted by fellow legal professionals.
Multidistrict & Class-Action Leadership
Dennis Reich and Robert Binstock have led complex multidistrict litigation and class-action claims, and have served on court-appointed plaintiffs' steering committees.
Proven Success Against National & Multinational Companies
A track record of multimillion-dollar verdicts and settlements against some of the largest corporations in the world.
Board Certified in Personal Injury Trial Law
A distinction earned by fewer than 1% of Texas attorneys — reserved for those who have demonstrated exceptional skill, experience, and professionalism in personal injury trial law.
How Much Does a Risperdal Breast Cancer Lawyer Cost?
Nothing upfront. Our law firm handles claims on a contingency-fee basis. This means clients pay nothing unless we recover compensation. Our Risperdal breast cancer attorneys only collect a percentage of the settlement or verdict we recover on your behalf, so there is no financial risk to you for seeking justice.
Contact our law firm today for a free case evaluation.
Contact a Risperdal Breast Cancer Attorney For a Free Consultation
If you or a loved one developed breast cancer after taking Risperdal, risperidone, or a related antipsychotic drug, it is time to take legal action. Missing the deadline permanently affects your right to file a Risperdal lawsuit. The Risperdal breast cancer attorneys at our law firm are helping men, women, and parents nationwide.
Call 713-622-7271 for a free evaluation to determine if you qualify.
There is never a fee unless we recover on your behalf.